Efficacy and safety of immune checkpoint inhibitors (ICI) for the treatment of metastatic penile squamous cell carcinoma (mPSCC).

被引：0
|
作者：
Cheng, Tiewei
Schieber, Timothy J.
Clennon, Anna
Bertken, Katie
Cai, Sunny Shengyuan
Wulff-Burchfield, Elizabeth Marie
Abbasi, Saqib
Parikh, Rahul Atul
Li, Haoran
机构：
[1] Univ Kansas, Med Ctr, Westwood, KS USA
[2] Univ Kansas, Canc Ctr, Westwood, KS USA
[3] Aurora St Lukes Med Ctr, Milwaukee, WI USA
[4] Univ Kansas Hlth Syst, Westwood, KS USA
[5] Univ Kansas, Med Ctr, Kansas City, KS USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 5_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.5_suppl.4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Immune Checkpoint Inhibitors in the Treatment of Renal Cell Carcinoma
    Parikh, Mamta
    Bajwa, Poornima
    SEMINARS IN NEPHROLOGY, 2020, 40 (01) : 76 - 85
  • [42] Radiotherapy combined with immune checkpoint inhibitors in locally advanced/metastatic esophageal squamous cell carcinoma: clinical trials, efficacy and future directions
    Jiang, Mengjie
    Hu, Yujie
    Lin, Gang
    Chen, Chao
    Li, Huafeng
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [43] Association of LIPI score with immune checkpoint inhibitors (ICI) outcomes in recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) patients (pts)
    Gomez, R. G. Herrera
    Mezquita, L.
    Auclin, E.
    Saleh, K.
    Rotllan, N. Baste
    Iacobs, M.
    Bursuc, S. C.
    Badis, L. Mayache
    Ferrand, F. R.
    Casiraghi, O.
    Temam, S.
    Breuskin, I.
    Tao, Y.
    Besse, B.
    Even, C.
    ANNALS OF ONCOLOGY, 2018, 29
  • [44] Immune checkpoints inhibitors in metastatic squamous cell carcinoma of the vulva
    Assi, Tarek
    Kattan, Joseph
    Othman, Ahmad
    Farhat, Fadi
    FUTURE ONCOLOGY, 2021, 17 (24)
  • [45] Evaluating safety and efficacy of immune checkpoint inhibitors (ICI) in elderly patients (pts) for advanced cancer treatment: A retrospective study
    Brixius, S. J.
    Meiss, F.
    von Bubnoff, D.
    Zeiser, R.
    Waller, C. F.
    Duyster, J.
    Rawluk, J.
    ANNALS OF ONCOLOGY, 2018, 29
  • [46] Immune Checkpoint Inhibitors for Treating Advanced Cutaneous Squamous Cell Carcinoma
    Patel, Roma
    Chang, Anne Lynn S.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2019, 20 (04) : 477 - 482
  • [47] Efficacy and Safety of Amrubicin in Small Cell Carcinoma Previously Treated with Immune Checkpoint Inhibitors and Chemotherapy
    Nishimura, Tadashi
    Fujimoto, Hajime
    Fujiwara, Takumi
    Ito, Kentaro
    Fujiwara, Atsushi
    Yuda, Hisamichi
    Itani, Hidetoshi
    Naito, Masahiro
    Kodama, Shuji
    Yagi, Akihiko
    D'Alessandro, Valeria Fridman
    Yasuma, Taro
    Furuhashi, Kazuki
    Saiki, Haruko
    Okano, Tomohito
    Tomaru, Atsushi
    Tanigawa, Motoaki
    D'Alessandro-Gabazza, Corina N.
    Gabazza, Esteban C.
    Yoshida, Masamichi
    Hataji, Osamu
    Ibata, Hidenori
    Kobayashi, Tetsu
    CANCERS, 2022, 14 (16)
  • [48] Immune checkpoint inhibitors in esophageal squamous cell carcinoma: progress and opportunities
    Jiao, Ruidi
    Luo, Hui
    Xu, Wenbo
    Ge, Hong
    ONCOTARGETS AND THERAPY, 2019, 12 : 6023 - 6032
  • [49] Rechallenge with immune checkpoint inhibitors for advanced esophageal squamous cell carcinoma
    Jin, Zhao
    Cao, Yanshuo
    Lu, Zhihao
    Liu, Chang
    Shen, Lin
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 137
  • [50] Immune Checkpoint Inhibitors for Treating Advanced Cutaneous Squamous Cell Carcinoma
    Roma Patel
    Anne Lynn S. Chang
    American Journal of Clinical Dermatology, 2019, 20 : 477 - 482
12345